Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Neuroblastoma × Potassium Iodide × Clear all

Phase

Status

No longer available 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neuroblastoma 1

Interventions

Cyclophosphamide 45 Etoposide 31 Filgrastim 27 Carboplatin 25 Doxorubicin 24 Vincristine 22 Melphalan 22 Isotretinoin 22 Topotecan 21 Granulocyte Colony-Stimulating Factor 19 Irinotecan 18 Peripheral Blood Stem Cell Transplantation 17 Cisplatin 16 sargramostim 15 Temozolomide 15 3-Iodobenzylguanidine 13 humanized 3F8 anti-GD2 monoclonal antibody 12 Radiotherapy 11 Granulocyte-Macrophage Colony-Stimulating Factor 10 dinutuximab 8 Busulfan 8 Interleukin-2 7 etoposide phosphate 6 aldesleukin 6 Stem Cell Transplantation 6 Polymerase Chain Reaction 6 Vorinostat 5 Thiotepa 5 Methylprednisolone 5 Ifosfamide 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03332667 2025-04-16

MIBG With Dinutuximab +/- Vorinostat

New Approaches to Neuroblastoma Therapy Consortium

Phase 1 Completed

45 enrolled 16 charts

Neuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡